Literature DB >> 30030494

Clinical tumour sequencing for precision oncology: time for a universal strategy.

Michael L Cheng1, Michael F Berger2,3, David M Hyman1, David B Solit4,5.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30030494      PMCID： PMC6618305          DOI： 10.1038/s41568-018-0043-2

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  9 in total

1.  Leveraging Systematic Functional Analysis to Benchmark an In Silico Framework Distinguishes Driver from Passenger MEK Mutants in Cancer.

Authors:  Aphrothiti J Hanrahan; Brooke E Sylvester; Matthew T Chang; Arijh Elzein; Jianjiong Gao; Weiwei Han; Ye Liu; Dong Xu; Sizhi P Gao; Alexander N Gorelick; Alexis M Jones; Amber J Kiliti; Moriah H Nissan; Clare A Nimura; Abigail N Poteshman; Zhan Yao; Yijun Gao; Wenhuo Hu; Hannah C Wise; Elena I Gavrila; Alexander N Shoushtari; Shakuntala Tiwari; Agnes Viale; Omar Abdel-Wahab; Taha Merghoub; Michael F Berger; Neal Rosen; Barry S Taylor; David B Solit
Journal:  Cancer Res       Date:  2020-07-08       Impact factor: 12.701

2.  Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma.

Authors:  François Audenet; Sumit Isharwal; Eugene K Cha; Mark T A Donoghue; Esther N Drill; Irina Ostrovnaya; Eugene J Pietzak; John P Sfakianos; Aditya Bagrodia; Paari Murugan; Guido Dalbagni; Timothy F Donahue; Jonathan E Rosenberg; Dean F Bajorin; Maria E Arcila; Jaclyn F Hechtman; Michael F Berger; Barry S Taylor; Hikmat Al-Ahmadie; Gopa Iyer; Bernard H Bochner; Jonathan A Coleman; David B Solit
Journal:  Clin Cancer Res       Date:  2018-10-23       Impact factor: 12.531

3.  Pan-cancer image-based detection of clinically actionable genetic alterations.

Authors:  Alexander T Pearson; Tom Luedde; Jakob Nikolas Kather; Lara R Heij; Heike I Grabsch; Chiara Loeffler; Amelie Echle; Hannah Sophie Muti; Jeremias Krause; Jan M Niehues; Kai A J Sommer; Peter Bankhead; Loes F S Kooreman; Jefree J Schulte; Nicole A Cipriani; Roman D Buelow; Peter Boor; Nadi-Na Ortiz-Brüchle; Andrew M Hanby; Valerie Speirs; Sara Kochanny; Akash Patnaik; Andrew Srisuwananukorn; Hermann Brenner; Michael Hoffmeister; Piet A van den Brandt; Dirk Jäger; Christian Trautwein
Journal:  Nat Cancer       Date:  2020-07-27

4.  MOLI: multi-omics late integration with deep neural networks for drug response prediction.

Authors:  Hossein Sharifi-Noghabi; Olga Zolotareva; Colin C Collins; Martin Ester
Journal:  Bioinformatics       Date:  2019-07-15       Impact factor: 6.937

5.  A qualitative transcriptional signature for predicting microsatellite instability status of right-sided Colon Cancer.

Authors:  Yelin Fu; Lishuang Qi; Wenbing Guo; Liangliang Jin; Kai Song; Tianyi You; Shuobo Zhang; Yunyan Gu; Wenyuan Zhao; Zheng Guo
Journal:  BMC Genomics       Date:  2019-10-23       Impact factor: 3.969

6.  Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples.

Authors:  Scott A Tomlins; Daniel H Hovelson; Jennifer M Suga; Daniel M Anderson; Han A Koh; Elizabeth C Dees; Brendan McNulty; Mark E Burkard; Michael Guarino; Jamil Khatri; Malek M Safa; Marc R Matrana; Eddy S Yang; Alex R Menter; Benjamin M Parsons; Jennifer N Slim; Michael A Thompson; Leon Hwang; William J Edenfield; Suresh Nair; Adedayo Onitilo; Robert Siegel; Alan Miller; Timothy Wassenaar; William J Irvin; William Schulz; Arvinda Padmanabhan; Vallathucherry Harish; Anneliese Gonzalez; Abdul Hai Mansoor; Andrew Kellum; Paul Harms; Stephanie Drewery; Jayson Falkner; Andrew Fischer; Jennifer Hipp; Kat Kwiatkowski; Lorena Lazo de la Vega; Khalis Mitchell; Travis Reeder; Javed Siddiqui; Hana Vakil; D Bryan Johnson; Daniel R Rhodes
Journal:  JCO Precis Oncol       Date:  2021-08-19

7.  Novel technologies in cfDNA analysis and potential utility in clinic.

Authors:  Jie Li; Mengyue Xu; Junya Peng; Jingqiao Wang; Yupei Zhao; Wenming Wu; Xun Lan
Journal:  Chin J Cancer Res       Date:  2021-12-31       Impact factor: 5.087

8.  Mutational signature and clonal relatedness of recurrent urothelial carcinomas with aristolochic acid.

Authors:  Jie Zhu; Qing Ai; Qiang Cheng; Dan Shen; Zhouhuan Dong; Jie Li; Donglai Shen; Wei Wang; Xu Zhang; Hongzhao Li
Journal:  Front Oncol       Date:  2022-09-14       Impact factor: 5.738

9.  Real-World Outcomes of an Automated Physician Support System for Genome-Driven Oncology.

Authors:  Jessica J Tao; Michael H Eubank; Alison M Schram; Nicholas Cangemi; Erika Pamer; Ezra Y Rosen; Nikolaus Schultz; Debyani Chakravarty; John Philip; Jaclyn F Hechtman; James J Harding; Lillian M Smyth; Komal L Jhaveri; Alexander Drilon; Marc Ladanyi; David B Solit; Ahmet Zehir; Michael F Berger; Peter D Stetson; Stuart M Gardos; David M Hyman
Journal:  JCO Precis Oncol       Date:  2019-07-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.